Tenet Healthcare Overview
Tenet Healthcare Target Price
Where could THC trade next? Consensus target price: $270.
Get informed when a big investor buys or sells
+ FollowShare Price
$254.78
Average Target Price
$269.31
5.7% upside
5.7% upside16 analysts in the last 4 months
High: $308 | Low: $210
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-28 | Goldman SachsScott Fidel | $305 | 19.7% upside |  |
| 2026-07-28 | Truist FinancialDavid MacDonald | $290 | 13.8% upside | |
| 2026-07-28 | Robert W. BairdMichael Ha | $280 | 9.9% upside | |
| 2026-07-27 | Stephens | $285 | 11.9% upside | |
| 2026-07-27 | UBS | $308 | 20.9% upside | |
| 2026-07-27 | Piper Sandler | $308 | 20.9% upside | |
| 2026-07-27 | Morgan Stanley | $274 | 7.5% upside | |
| 2026-07-27 | Raymond JamesSarah James | $270 | 6% upside | |
| 2026-07-27 | RBC Capital | $283 | 11.1% upside | |
| 2026-07-24 | Barclays | $271 | 6.4% upside | |
| 2026-07-20 | Guggenheim | $242 |  5% downside | |
| 2026-07-13 | Wells FargoStephen Baxter | $231 | 9.3% downside | |
| 2026-05-05 | Robert W. Baird | $210 | 17.6% downside | |
| 2026-05-05 | BarclaysAndrew Mok | $238 | 6.6% downside | |
| 2026-05-04 | StephensScott Fidel | $260 | 2% upside | |
| 2026-05-01 | Morgan Stanley | $254 | 0.3% downside | |
| 2026-03-12 | GuggenheimJason Cassorla | $283 | 11.1% upside | |
| 2026-02-17 | Truist Financial | $270 | 6% upside | |
| 2026-02-16 | Wells FargoStephen Baxter | $265 | 4% upside | |
| 2026-02-13 | Guggenheim | $271 | 6.4% upside | |
| 2026-02-13 | BarclaysAndrew Mok | $257 | 0.9% upside | |
| 2026-02-12 | UBS | $288 | 13% upside | |
| 2026-02-12 | Morgan Stanley | $260 | 2% upside | |
| 2026-02-12 | RBC Capital | $277 | 8.7% upside | |
| 2026-02-12 | KeyBancMatthew Gillmor | $250 | 1.9% downside | |
| 2026-02-03 | RBC CapitalBen Hendrix | $253 | 0.7% downside | |
| 2026-01-07 | Wells Fargo | $229 | 10.1% downside | |
| 2025-12-18 | Morgan StanleyCraig Hettenbach | $247 | 3.1% downside | |
| 2025-12-02 | Guggenheim | $257 | 0.9% upside | |
| 2025-11-21 | BarclaysAndrew Mok | $240 | 5.8% downside | |
| 2025-11-03 | Truist Financial | $240 | 5.8% downside | |
| 2025-10-30 | RBC Capital | $252 | 1.1% downside | |
| 2025-10-29 | Raymond JamesSarah James | $245 | 3.8% downside | |
| 2025-10-29 | UBS | $260 | 2% upside | |
| 2025-10-29 | Morgan Stanley | $232 | 8.9% downside | |
| 2025-10-29 | Guggenheim | $238 | 6.6% downside | |
| 2025-10-17 | Mizuho SecuritiesAnn Hynes | $225 | 11.7% downside | |
| 2025-10-14 | Truist FinancialDavid MacDonald | $225 | 11.7% downside | |
| 2025-10-14 | Goldman SachsScott Fidel | $224 | 12.1% downside | |
| 2025-10-08 | KeyBancMatthew Gillmor | $225 | 11.7% downside | |
| 2025-10-07 | Wells FargoStephen Baxter | $238 | 6.6% downside | |
| 2025-09-18 | Barclays | $229 | 10.1% downside | |
| 2025-07-16 | Truist FinancialDavid MacDonald | $205 | 19.5% downside | |
| 2025-03-26 | Morgan Stanley | $165 | 35.2% downside | |
| 2025-01-07 | KeyBancMatthew Gillmor | $185 | 27.4% downside | |
| 2024-12-16 | Goldman SachsJamie Perse | $140 | 45.1% downside | |
| 2024-10-29 | Wolfe ResearchJustin Lake | $178 | 30.1% downside | |
| 2024-07-26 | Mizuho SecuritiesAnn Hynes | $170 | 33.3% downside | |
| 2024-07-25 | Truist FinancialDavid MacDonald | $170 | 33.3% downside | |
| 2024-07-15 | Truist FinancialDavid MacDonald | $155 | 39.2% downside | |